Medscape | First-in-Class Drug Shows Activity in Advanced Blood Cancers Medscape Some of the patients in the study had relapsed after bone marrow transplantation; in these patients, survival is typically very poor, he explained. "These are extremely exciting results." The primary goal of this phase 1 study was to determine the ... |
